Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the changes in serum aldosterone and plasma renin activity on Day 0 and on Days 1
and 10 after administration of 100 mg of eplerenone daily for 10 days.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.